COSMOS Pharmaceutical Corporation (TYO:3349)

COSMOS Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is June - May.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Market Capitalization	591,418	502,890	525,081	483,107	603,094	612,599
Market Cap Growth	-5.55%	-4.23%	8.69%	-19.89%	-1.55%	80.30%
Enterprise Value	577,964	495,143	507,058	456,292	562,389	598,485
Last Close Price	7462.00	6316.54	6544.04	5977.58	7420.84	7505.35
PE Ratio	21.67	20.57	22.07	20.86	22.21	28.58
Forward PE	20.02	19.07	21.97	19.33	24.17	28.75
PS Ratio	0.59	0.52	0.63	0.64	0.83	0.90
PB Ratio	2.43	2.17	2.49	2.54	3.54	4.21
P/TBV Ratio	2.41	2.18	2.49	2.54	3.54	4.21
P/FCF Ratio	167.30	-	67.33	-	333.02	15.50
P/OCF Ratio	10.98	9.11	9.65	15.01	21.64	9.36
PEG Ratio	2.16	2.90	5.05	4.03	2.32	1.92
EV/Sales Ratio	0.58	0.51	0.61	0.60	0.77	0.87
EV/EBITDA Ratio	10.12	9.63	10.68	10.16	11.98	14.03
EV/EBIT Ratio	16.05	15.72	16.83	15.31	16.97	20.57
EV/FCF Ratio	163.50	-	65.02	-	310.54	15.15
Debt / Equity Ratio	0.11	0.15	0.09	0.05	0.06	0.08
Debt / EBITDA Ratio	0.45	0.66	0.38	0.21	0.22	0.28
Debt / FCF Ratio	7.26	-	2.33	-	5.77	0.31
Asset Turnover	2.16	2.15	2.11	2.15	2.20	2.31
Inventory Turnover	8.85	9.49	9.16	9.52	10.19	10.28
Quick Ratio	0.19	0.30	0.29	0.28	0.39	0.36
Current Ratio	0.71	0.72	0.71	0.71	0.78	0.71
Return on Equity (ROE)	11.76%	11.05%	11.85%	12.83%	17.17%	15.76%
Return on Assets (ROA)	4.88%	4.39%	4.80%	5.29%	6.26%	6.12%
Return on Capital (ROIC)	8.98%	7.96%	8.77%	9.78%	12.23%	12.21%
Return on Capital Employed (ROCE)	13.20%	12.00%	13.20%	14.80%	18.20%	18.40%
Earnings Yield	4.62%	4.86%	4.53%	4.79%	4.50%	3.50%
FCF Yield	0.60%	-0.13%	1.49%	-2.34%	0.30%	6.45%
Dividend Yield	0.87%	0.95%	0.76%	0.67%	0.47%	0.37%
Payout Ratio	17.44%	19.05%	13.72%	14.11%	8.38%	9.69%
Buyback Yield / Dilution	-0.06%	-0.05%	0.00%	0.00%	0.00%	-
Total Shareholder Return	0.81%	0.90%	0.76%	0.67%	0.47%	0.37%

Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.